Claims

Search Type State Status Topic Model Order Counting Over

As of snapshot 27745 under ledger-default@0.3.0.

Claim	Type	Assessment	Score	Review checks	References
In the study’s 14,644-patient RW2 cohort, EAGLE-Plus reduced false positives by 72.7% while maintaining comparable sensitivity.	QUANTITATIVE	Supported	0.8808	1 of 4	136
In the study’s eight-center external CT test cohorts, EAGLE achieved 98.5% specificity, 90.0% cancer sensitivity and 52.5% precancerous-lesion sensitivity.	QUANTITATIVE	Supported	0.9781	1 of 4	141
The EAGLE model was trained on 6,813 patients and validated across 12 centers in three countries involving 80,612 patients.	QUANTITATIVE	Supported	0.9734	1 of 4	125